CAESARSTONE LTD (CSTE) Stock Fundamental Analysis

NASDAQ:CSTE • IL0011259137

1.37 USD
-0.11 (-7.43%)
Last: Feb 27, 2026, 08:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Overall CSTE gets a fundamental rating of 2 out of 10. We evaluated CSTE against 42 industry peers in the Building Products industry. The financial health of CSTE is average, but there are quite some concerns on its profitability. CSTE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year CSTE has reported negative net income.
  • In the past year CSTE has reported a negative cash flow from operations.
  • In multiple years CSTE reported negative net income over the last 5 years.
  • Of the past 5 years CSTE 4 years had a positive operating cash flow.
CSTE Yearly Net Income VS EBIT VS OCF VS FCFCSTE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

  • The Return On Assets of CSTE (-13.97%) is worse than 80.95% of its industry peers.
  • CSTE's Return On Equity of -30.04% is on the low side compared to the rest of the industry. CSTE is outperformed by 76.19% of its industry peers.
Industry RankSector Rank
ROA -13.97%
ROE -30.04%
ROIC N/A
ROA(3y)-11.12%
ROA(5y)-6.06%
ROE(3y)-20.4%
ROE(5y)-11.19%
ROIC(3y)N/A
ROIC(5y)N/A
CSTE Yearly ROA, ROE, ROICCSTE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

  • With a Gross Margin value of 19.38%, CSTE is not doing good in the industry: 73.81% of the companies in the same industry are doing better.
  • CSTE's Gross Margin has declined in the last couple of years.
  • CSTE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.38%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.44%
GM growth 5Y-4.33%
CSTE Yearly Profit, Operating, Gross MarginsCSTE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • CSTE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for CSTE remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for CSTE has been increased compared to 5 years ago.
  • CSTE has a better debt/assets ratio than last year.
CSTE Yearly Shares OutstandingCSTE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
CSTE Yearly Total Debt VS Total AssetsCSTE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

  • CSTE has an Altman-Z score of 1.29. This is a bad value and indicates that CSTE is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.29, CSTE is doing worse than 83.33% of the companies in the same industry.
  • A Debt/Equity ratio of 0.00 indicates that CSTE is not too dependend on debt financing.
  • CSTE has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. CSTE outperforms 92.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 1.29
ROIC/WACCN/A
WACC8.34%
CSTE Yearly LT Debt VS Equity VS FCFCSTE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

  • A Current Ratio of 2.07 indicates that CSTE has no problem at all paying its short term obligations.
  • CSTE has a Current ratio (2.07) which is in line with its industry peers.
  • CSTE has a Quick Ratio of 1.36. This is a normal value and indicates that CSTE is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of CSTE (1.36) is better than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 2.07
Quick Ratio 1.36
CSTE Yearly Current Assets VS Current LiabilitesCSTE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • The earnings per share for CSTE have decreased strongly by -73.42% in the last year.
  • The Revenue for CSTE has decreased by -15.45% in the past year. This is quite bad
  • CSTE shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.09% yearly.
EPS 1Y (TTM)-73.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.67%
Revenue 1Y (TTM)-15.45%
Revenue growth 3Y-11.71%
Revenue growth 5Y-4.09%
Sales Q2Q%-5.13%

3.2 Future

  • CSTE is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.55% yearly.
  • The Revenue is expected to decrease by -2.34% on average over the next years.
EPS Next Y-66.05%
EPS Next 2Y-8.91%
EPS Next 3Y3.55%
EPS Next 5YN/A
Revenue Next Year-10.85%
Revenue Next 2Y-4.83%
Revenue Next 3Y-2.34%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CSTE Yearly Revenue VS EstimatesCSTE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
CSTE Yearly EPS VS EstimatesCSTE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CSTE. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CSTE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CSTE Price Earnings VS Forward Price EarningsCSTE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CSTE Per share dataCSTE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-8.91%
EPS Next 3Y3.55%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for CSTE!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CAESARSTONE LTD

NASDAQ:CSTE (2/27/2026, 8:00:00 PM)

1.37

-0.11 (-7.43%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)02-25
Earnings (Next)05-05
Inst Owners27.86%
Inst Owner Change-32.06%
Ins Owners1.65%
Ins Owner ChangeN/A
Market Cap47.36M
Revenue(TTM)400.66M
Net Income(TTM)-70.09M
Analysts82.86
Price Target4.08 (197.81%)
Short Float %0.48%
Short Ratio0.83
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-57.48%
Min EPS beat(2)-79.74%
Max EPS beat(2)-35.23%
EPS beat(4)1
Avg EPS beat(4)-38.25%
Min EPS beat(4)-79.74%
Max EPS beat(4)11.15%
EPS beat(8)3
Avg EPS beat(8)-28.89%
EPS beat(12)3
Avg EPS beat(12)-233.01%
EPS beat(16)4
Avg EPS beat(16)-183.76%
Revenue beat(2)1
Avg Revenue beat(2)-2.34%
Min Revenue beat(2)-7.26%
Max Revenue beat(2)2.57%
Revenue beat(4)2
Avg Revenue beat(4)-1.89%
Min Revenue beat(4)-7.26%
Max Revenue beat(4)2.57%
Revenue beat(8)3
Avg Revenue beat(8)-4.15%
Revenue beat(12)3
Avg Revenue beat(12)-5.84%
Revenue beat(16)4
Avg Revenue beat(16)-4.38%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-35.71%
EPS NY rev (1m)0%
EPS NY rev (3m)-16.67%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.85%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.59%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.12
P/FCF N/A
P/OCF N/A
P/B 0.2
P/tB 0.2
EV/EBITDA N/A
EPS(TTM)-1.37
EYN/A
EPS(NY)-1.02
Fwd EYN/A
FCF(TTM)-1.2
FCFYN/A
OCF(TTM)-0.9
OCFYN/A
SpS11.59
BVpS6.75
TBVpS6.75
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -13.97%
ROE -30.04%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.38%
FCFM N/A
ROA(3y)-11.12%
ROA(5y)-6.06%
ROE(3y)-20.4%
ROE(5y)-11.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.44%
GM growth 5Y-4.33%
F-Score2
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 71.22%
Cap/Sales 2.6%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.07
Quick Ratio 1.36
Altman-Z 1.29
F-Score2
WACC8.34%
ROIC/WACCN/A
Cap/Depr(3y)49.02%
Cap/Depr(5y)60.64%
Cap/Sales(3y)2.3%
Cap/Sales(5y)3.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-73.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-66.67%
EPS Next Y-66.05%
EPS Next 2Y-8.91%
EPS Next 3Y3.55%
EPS Next 5YN/A
Revenue 1Y (TTM)-15.45%
Revenue growth 3Y-11.71%
Revenue growth 5Y-4.09%
Sales Q2Q%-5.13%
Revenue Next Year-10.85%
Revenue Next 2Y-4.83%
Revenue Next 3Y-2.34%
Revenue Next 5YN/A
EBIT growth 1Y-69.95%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1.38%
EBIT Next 3Y24.13%
EBIT Next 5YN/A
FCF growth 1Y-201.95%
FCF growth 3YN/A
FCF growth 5Y-18.43%
OCF growth 1Y-157.02%
OCF growth 3Y15.48%
OCF growth 5Y-17.42%

CAESARSTONE LTD / CSTE FAQ

What is the ChartMill fundamental rating of CAESARSTONE LTD (CSTE) stock?

ChartMill assigns a fundamental rating of 2 / 10 to CSTE.


Can you provide the valuation status for CAESARSTONE LTD?

ChartMill assigns a valuation rating of 0 / 10 to CAESARSTONE LTD (CSTE). This can be considered as Overvalued.


What is the profitability of CSTE stock?

CAESARSTONE LTD (CSTE) has a profitability rating of 1 / 10.


What is the financial health of CAESARSTONE LTD (CSTE) stock?

The financial health rating of CAESARSTONE LTD (CSTE) is 4 / 10.


Can you provide the expected EPS growth for CSTE stock?

The Earnings per Share (EPS) of CAESARSTONE LTD (CSTE) is expected to decline by -66.05% in the next year.